UCLA study description
Open this page in the complete interactive Atlas
The study team explains the rationale for studying social motivation in a selected group of people with stable illness.
Reading the evidence map
The investigators plan to assess psychotic symptoms 24 hours after exposure in people with stable schizophrenia. The rationale concerns social motivation.
Where this source fits
MDMA · Schizophrenia · tolerability and social motivation
UCLA plans to study 20 adults with clinically stable schizophrenia. Investigators monitor disorganized speech, delusions and hallucinations and explore whether MDMA changes social motivation. This is an early test of whether further study is feasible.
The registry lists recruiting and has no posted outcomes. There is no demonstrated benefit for schizophrenia symptoms, acute psychosis or catatonia from this trial.
Reading basis · Original source summarized in the experimental-drug section
Original source
https://www.uclahealth.org/clinical-trials/tolerability-mdma-schizophrenia